Anna J. Roy

The TREAT-NMD DMD Global Database: Analysis of More than 7,000 Duchenne Muscular Dystrophy Mutations

Catherine L. Bladen, David Salgado, Soledad Monges et al. · Human Mutation · 2015 · 744 citations · Full text

Life Sciences, Genetics, Molecular Genetics +15

Clinical Outcomes in Duchenne Muscular Dystrophy: A Study of 5345 Patients from the TREAT-NMD DMD Global Database

Zaïda Koeks, Catherine L. Bladen, David Salgado et al. · Journal of Neuromuscular Diseases · 2017 · 182 citations · Full text

Medicine, Neurology, Clinical Epidemiology +4

The TREAT-NMD Duchenne Muscular Dystrophy Registries: Conception, Design, and Utilization by Industry and Academia

Catherine L. Bladen, Karen Rafferty, Volker Straub et al. · Human Mutation · 2013 · 108 citations

Medicine, Neurology, Good Clinical Practice +13

Early stages of building a rare disease registry, methods and 2010 data from the Belgian Neuromuscular Disease Registry (BNMDR)

Anna J. Roy, Peter Van den Bergh, Philip Van Damme et al. · Acta Neurologica Belgica · 2014 · 27 citations · Full text

Veterinary Medicine, Health Sciences, Neurology +14

How robust is ACTIVLIM for the follow-up of activity limitations in patients with neuromuscular diseases?

Charles Sèbiyo Batcho, Peter Van den Bergh, Philip Van Damme et al. · Neuromuscular Disorders · 2015 · 21 citations · Full text

Medicine, Neurology, Physical Medicine +14